| 소속 | |||
|---|---|---|---|
| 진료분야 | 폐암, 폐결절 | ||
| 학력 | 부산대학교 의학전문대학원 졸업 (석사) 부산대학교 의과대학 (박사) |
||
| 경력 | 고려대학교 의료원 수련의 부산대학교병원 내과 전공의 부산대학교병원 전임의 부산대학교병원 진료조교수 동아대학병원 임상조교수 일본 Shimane University Hospital 연수 동아대학교 의과대학 내과학교실 조교수 일본 Nagoya Medical Center 연수 |
||
| 현직 | 동아대학교 의과대학 내과학교실 부교수 동아대학교병원 의료정보센터 소장 |
||
| 학회활동 및 사회활동 |
대한내과학회 정회원 대한결핵 및 호흡기학회 정회원 대한결핵 및 호흡기학회 기관지경연구회 정회원 대한폐암학회 정회원 대한폐암학회 표적치료연구회 정회원 유럽 호흡기학회 회원 아시아-태평양 호흡기학회 회원 세계기관지경학회 정회원 미국임상종양학회 정회원 국제폐암연구협회 정회원 |
||
| 연구 | ● Kim I, Eom JS, Kim AR, Lee CH, Lee G, Jo EJ, Kim MH, Mok JH, Lee K, Kim KU, Park HK, Lee MK. Molecular analysis of small tissue samples obtained via transbronchial lung biopsy using radial probe endobronchial ultrasound. PLoS One. 2019 Feb 26;14(2):e0212672. ● Kim I, Kim A, Lee CH, Lee G, Kim A, Jo EJ, Kim MH, Mok J, Lee K, Kim KU, Park HK, Lee MK, Eom JS.Reliability of PD-L1 assays using small tissuesamples compared with surgical specimens. Medicine (Baltimore). 2019 Apr;98(14):e14972 ● Kim I, Eom JS, Jo EJ, Mok J, Lee K, Uk Kim K, Park HK, Lee MK, Kim MH.Prognostic value of quantitative measurement of EGFR mutation using peptide nucleic acid clamping in advanced EGFR mutant non-small cell lung cancer patients.Thorac Cancer. 2019 Jul;10(7):1561-1566. ● Kim I, Lee G, Eom JS, Ahn HY, Kim A. Feasibility of low dose chest CT for virtual bronchoscopy navigation in a porcine model.Respir Res. 2019 Jul 8;20(1):142. ● Roh J, Ahn HY, Kim I, Son JH, Seol HY, Kim MH, Lee MK, Eom JS.Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients: A multicenter retrospective study. Medicine (Baltimore). 2021 May 14;100(19) ● Kim I, Seol HY, Kim SH, Kim MH, Lee MK, Eom JS. Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer. Cancers (basel). 2023 Feb 24;15(5):1445. ● Kim SH, Chung HS, Kim J, Kim MH, Lee MK, Kim I, Eom JS. Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated meta-Analysis. Cancer Res Treat. 2023 Nov 29. doi: 10.4143/crt.2023.749. ● Park, J. E., Hong, K. S., Choi, S. H., Lee, S. Y., Shin, K. C., Jang, J. G., Kwon, Y. S., Park, S. H., Choi, K. J., Jung, C. Y., Eom, J. S., Kim, S., Seol, H. Y., Kim, J., Kim, I., Park, J. H., Kim, T. H., &Ahn, J. H.Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study. Clinical lung cancer, 2024 Jun;25(4):354-364. ● Kim, I., Choi, S. H., Lee, S. Y., Yoo, S. S., Park, J. E., Shin, K. C., Jang, J. G., Hong, K. S., Kwon, Y. S., Park, S. H., Choi, K. J., Jung, C. Y., Kim, M. H., Kim, S. H., Seol, H. Y., Kim, J., Park, J. H., Kim, T. H., Eom, J. S., &Ahn, J. H. PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC. Anticancer research, 2024 Oct;44(10):4505-4516. ● Park JE, Kim C, Choi SH, Jang JG, Hong KS, Kwon YS, Choi KJ, Eom JS, Kim S, Seol HY, Kim J, Kim I, Park JH, Kim TH, Ahn JH. Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy. Transl Lung Cancer Res. 2025 Apr 30;14(4):1149-1157. doi: 10.21037/tlcr-2024-1112. Epub 2025 Apr 18. ● Kim MH, Lee MK, Park JE, Park SH, Jang TW, Jung CY, Kim I, Yoon SH, Ahn JH, Lee HK, Park JH, Choi SH, Eom JS. Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With EGFR-Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study. Thorac Cancer. 2025 May;16(10):e70083. ● Ahn JH, Choi SH, Park SH, Kim I, Park JH, Kim JY, Kim TH, Lee T, Cho HK, Jeong JH, Yang JW, Park JE, Kim TH, Lee HK, Lee HY, Jung HJ, Kim J, Son J, Eom JS. Longitudinal Analysis of Recurrence and Risk Factors of Early-Stage Resected Adenocarcinoma With Common EGFR Mutations: A Multicenter Retrospective Cohort Study in South Korea. Clin Lung Cancer. 2025 Jun;26(4):314-323. ● Kim MH, Seong H, Kim SH, Lee MK, Kim I, Hong KS, Ahn JH, Eom JS. Efficacy and safety of first-line afatinib in older patients with advanced EGFR-mutated non-small cell lung cancer. Korean J Intern Med. 2025 Jul;40(4):626-633. doi: 10.3904/kjim.2024.269. Epub 2025 Jul 1. ● Park SH, Park JH, Kim TH, Choi SH, Park JE, Kim I, Kim JY, Kim TH, Lee T, Cho HK, Jeong JH, Yang JW, Lee HK, Lee HY, Jung HJ, Eom JS, Ahn JH. Adjuvant chemotherapy before osimertinib in EGFR-mutated stage IB lung adenocarcinoma: a clinical dilemma. Transl Lung Cancer Res. 2025 Sep 30;14(9):3542-3552. doi: 10.21037/tlcr-2025-348. Epub 2025 Sep 25. ● Kim DH, Kang BH, Um S-J, Kim I. Diagnostic Value of Bronchoscopy in Detecting Laryngopharyngeal Disorders: Clinical Utility and Limitations. Medicina. 2025; 61(9):1617. https://doi.org/10.3390/medicina61091617 |
||
| 저서 | 기관지내시경 교과서 (대한결핵 및 호흡기학회 저) | ||